Literature DB >> 6172599

Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA.

L I Messer, J G Levin, S K Chattopadhyay.   

Abstract

Molecular hybridization techniques were used to examine the stability of viral message and virion precursor RNA in murine leukemia virus-infected cells treated with actinomycin D. Under the conditions used, viral RNA synthesis was inhibited, but viral protein synthesis continued, and the cells produced noninfectious particles (actinomycin D virions) lacking genomic RNA (J. G. Levin and M. J. Rosenak, Proc. Natl. Acad. Sci. U.S.A. 73:1154-1158, 1976). Analysis of total RNA in virions revealed that the amount of hybridizable viral RNA decreased steadily after the addition of actinomycin D and by 8 h was 10% of the control value. Studies on fractionated viral RNA showed that this low level of hybridization is due to residual 70S RNA in the virion population. The results indicated that viral RNA which is destined to be encapsidated into virions has a half-life of approximately 3 to 4 h. In contrast, other intracellular virus-specific RNA molecules appeared to be quite stable and persisted for a long period of time, with a half-life of at least 12 h. These observations support the idea that two independent functional pools of 35S viral RNA exist within the infected cell: one serving as message and the other as precursor to virion RNA. The existence of two viral RNA pools was further documented by the finding that 12 h after the addition of actinomycin D, when virion precursor RNA was depleted, 35S and 21S viral nRNA species could be identified in polyribosomal RNA as well as in total polyadenylated cell RNA. Surprisingly, 35S and mRNA declined more rapidly than did 21S mRNA, which appeared to be increased in amount.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172599      PMCID: PMC256680          DOI: 10.1128/JVI.40.3.683-690.1981

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Evidence for splicing of avian sarcoma virus 5'-terminal genomic sequences into viral-specific RNA in infected cells.

Authors:  R A Krzyzek; M S Collett; A F Lau; M L Perdue; J P Leis; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Synthesis of the RNA of RNA-containing tumor viruses. I. The interval between synthesis and envelopment.

Authors:  J P Bader
Journal:  Virology       Date:  1970-03       Impact factor: 3.616

3.  The virus-specific RNA species in free and membrane-bound polyribosomes of transformed cells replicating murine sarcoma-leukemia viruses.

Authors:  G Shanmugam; S Bhaduri; M Green
Journal:  Biochem Biophys Res Commun       Date:  1974-02-04       Impact factor: 3.575

4.  RNA in mammalian sarcoma virus transformed nonproducer cells homologous to murine leukemia virus RNA.

Authors:  R E Benveniste; E M Scolnick
Journal:  Virology       Date:  1973-02       Impact factor: 3.616

5.  Stability of HeLa cell mRNA in actinomycin.

Authors:  R H Singer; S Penman
Journal:  Nature       Date:  1972-11-10       Impact factor: 49.962

6.  RNA metabolism of murine leukemia virus: detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA.

Authors:  H Fan; D Baltimore
Journal:  J Mol Biol       Date:  1973-10-15       Impact factor: 5.469

7.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Inhibition of mouse leukemia virus (MLV) replication by actinomycin D.

Authors:  P H Duesberg; W S Robinson
Journal:  Virology       Date:  1967-04       Impact factor: 3.616

9.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  Incorporation of precursors into ribonucleic acid, protein, glycoprotein, and lipoprotein of avian myeloblastosis virions.

Authors:  M A Baluda; D P Nayak
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

View more
  17 in total

Review 1.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.

Authors:  M Butsch; K Boris-Lawrie
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random.

Authors:  Jessica A Flynn; Alice Telesnitsky
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

Review 4.  Insights into the nuclear export of murine leukemia virus intron-containing RNA.

Authors:  Lucie Pessel-Vivares; Laurent Houzet; Sébastien Lainé; Marylène Mougel
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  Nonrandom dimerization of murine leukemia virus genomic RNAs.

Authors:  Jessica A Flynn; Wenfeng An; Steven R King; Alice Telesnitsky
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus.

Authors:  N Dorman; A Lever
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 7.  Retrovirus translation initiation: Issues and hypotheses derived from study of HIV-1.

Authors:  Alper Yilmaz; Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Curr HIV Res       Date:  2006-04       Impact factor: 1.581

8.  Maturation of dimeric viral RNA of Moloney murine leukemia virus.

Authors:  W Fu; A Rein
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions.

Authors:  Silas F Johnson; John T Collins; Victoria M D'Souza; Alice Telesnitsky
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

10.  Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.

Authors:  J Guo; T Wu; J Bess; L E Henderson; J G Levin
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.